IHC testing of MLH1, PMS2, MSH2, and MSH6 is recommended for all DS cancers of the Lynch syndrome spectrum including adenocarcinomas of the gastroesophageal junction, small bowel, and colorectum. The gene discussed is MSH6; the disease is Lynch syndrome.